GE HealthCare Technologies Inc. $GEHC Shares Sold by Gateway Investment Advisers LLC

Gateway Investment Advisers LLC lowered its stake in GE HealthCare Technologies Inc. (NASDAQ:GEHCFree Report) by 31.2% during the third quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 21,918 shares of the company’s stock after selling 9,937 shares during the quarter. Gateway Investment Advisers LLC’s holdings in GE HealthCare Technologies were worth $1,646,000 at the end of the most recent quarter.

Several other hedge funds also recently bought and sold shares of GEHC. Thoma Capital Management LLC raised its stake in shares of GE HealthCare Technologies by 2.8% in the 3rd quarter. Thoma Capital Management LLC now owns 9,782 shares of the company’s stock valued at $735,000 after acquiring an additional 269 shares during the period. Golden State Equity Partners purchased a new stake in GE HealthCare Technologies in the third quarter valued at approximately $206,000. Salomon & Ludwin LLC raised its position in GE HealthCare Technologies by 326.5% in the third quarter. Salomon & Ludwin LLC now owns 482 shares of the company’s stock valued at $37,000 after purchasing an additional 369 shares during the period. Massachusetts Wealth Management lifted its stake in GE HealthCare Technologies by 4.3% during the third quarter. Massachusetts Wealth Management now owns 14,231 shares of the company’s stock worth $1,069,000 after purchasing an additional 584 shares in the last quarter. Finally, Mather Group LLC. purchased a new position in shares of GE HealthCare Technologies during the third quarter worth $141,000. Hedge funds and other institutional investors own 82.06% of the company’s stock.

Wall Street Analysts Forecast Growth

Several equities research analysts recently issued reports on GEHC shares. Citigroup boosted their price objective on GE HealthCare Technologies from $83.00 to $88.00 and gave the company a “neutral” rating in a report on Thursday, December 11th. Bank of America boosted their price target on shares of GE HealthCare Technologies from $82.00 to $92.00 and gave the stock a “neutral” rating in a research note on Monday. Wall Street Zen cut shares of GE HealthCare Technologies from a “buy” rating to a “hold” rating in a report on Saturday, September 20th. Jefferies Financial Group upped their target price on shares of GE HealthCare Technologies from $95.00 to $105.00 and gave the stock a “buy” rating in a research note on Thursday, December 11th. Finally, Evercore ISI reissued an “outperform” rating and issued a $95.00 price target on shares of GE HealthCare Technologies in a research report on Monday. Six research analysts have rated the stock with a Buy rating and seven have issued a Hold rating to the company’s stock. According to data from MarketBeat, the stock currently has an average rating of “Hold” and an average price target of $87.75.

Read Our Latest Analysis on GEHC

GE HealthCare Technologies Stock Up 2.7%

GEHC stock opened at $85.04 on Tuesday. The company’s 50 day moving average price is $79.48 and its 200 day moving average price is $76.30. The firm has a market capitalization of $38.74 billion, a price-to-earnings ratio of 17.57, a PEG ratio of 3.20 and a beta of 1.08. GE HealthCare Technologies Inc. has a fifty-two week low of $57.65 and a fifty-two week high of $94.80. The company has a debt-to-equity ratio of 0.83, a quick ratio of 0.95 and a current ratio of 1.18.

GE HealthCare Technologies (NASDAQ:GEHCGet Free Report) last posted its quarterly earnings results on Wednesday, October 29th. The company reported $1.07 EPS for the quarter, topping the consensus estimate of $1.05 by $0.02. GE HealthCare Technologies had a net margin of 10.94% and a return on equity of 22.52%. The company had revenue of $5.14 billion during the quarter, compared to analysts’ expectations of $5.07 billion. During the same quarter in the previous year, the business posted $1.14 EPS. The firm’s revenue was up 5.8% on a year-over-year basis. GE HealthCare Technologies has set its FY 2025 guidance at 4.510-4.630 EPS. On average, equities research analysts anticipate that GE HealthCare Technologies Inc. will post 4.68 EPS for the current fiscal year.

GE HealthCare Technologies Announces Dividend

The firm also recently announced a quarterly dividend, which will be paid on Friday, February 13th. Investors of record on Friday, January 9th will be issued a $0.035 dividend. This represents a $0.14 annualized dividend and a yield of 0.2%. The ex-dividend date of this dividend is Friday, January 9th. GE HealthCare Technologies’s dividend payout ratio is 2.89%.

GE HealthCare Technologies Profile

(Free Report)

GE HealthCare Technologies (NASDAQ: GEHC) is a global medical technology and diagnostics company that develops, manufactures and markets a broad range of products and services for healthcare providers. Its portfolio centers on diagnostic imaging systems, including MRI, CT, PET and X-ray modalities, as well as ultrasound equipment. The company also supplies patient monitoring and anesthesia delivery systems, interventional and surgical imaging solutions, and molecular imaging technologies used in both clinical care and research settings.

In addition to hardware, GE HealthCare offers software, analytics and lifecycle services aimed at improving clinical workflows and equipment uptime.

Featured Stories

Want to see what other hedge funds are holding GEHC? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for GE HealthCare Technologies Inc. (NASDAQ:GEHCFree Report).

Institutional Ownership by Quarter for GE HealthCare Technologies (NASDAQ:GEHC)

Receive News & Ratings for GE HealthCare Technologies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for GE HealthCare Technologies and related companies with MarketBeat.com's FREE daily email newsletter.